glp 1 agents GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? Current Insights, Advantages and Challenges
Description
These large studies did not identify increased fracture risk compared to placebo, providing some reassurance regarding skeletal safety
This doesnt mean everyone with obesity has a GLP-1 issue and, ultimately, people must change their behaviors to improve their outcomes
The dose should be individualized based on response, tolerability, safety, nutrition, body composition, and clinical goals
Gila monsters fueled the current monster diet revolution
Well, let me tell you something
